19 May 2013
Keywords: peregrine, deal, niaid, anglo-swedish, drug, major, astrazeneca
Article | 25 June 2007
Anglo-Swedish drug major AstraZeneca says that, following a comprehensive analysis of pre- and post-marketing data by the UK's
Medicines and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 June 2007
18 June 2007
17 May 2013
© 2013 thepharmaletter.com